Clinical Trial Results

Showing: All studies [change]
Condition: Hypertension Location: Rochester, New York 13 trials found
New Search
Filter
Trial Phase
Study Type
Pulmonary Hypertension Association Registry
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NAINTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
PHASE3INTERVENTIONAL Fresno, California +4 more
RECRUITING
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
PHASE3INTERVENTIONAL Alexander City, Alabama +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
NAINTERVENTIONAL Rochester, New York
RECRUITING
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type